Aquestive Therapeutics (AQST)
Develops PharmFilm oral medicines and manufactures licensed films for global partners.
$4.91
After hours−0.03 (−0.61%)
At close$4.94(+3.35%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 57.62% | 72.32M shares | |
|---|---|---|---|
| 195 holders · as of Jun 30, 2026 | |||
| Insiders | 3.39% | 4.25M shares | |
| 14 holders · as of Sep 16, 2026 | |||
| Other | 38.99% | 48.94M shares | |
| remainder | |||
125.51M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
195 holders · 72.32M shares · 28 new positions · 98 increased · 43 reduced · 20 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9.81M | 7.82% | 0 | Aug 11, 2026 |
| BlackRock, Inc. | 8.07M | 6.43% | +560.3K | Aug 7, 2026 |
| RTW Investments, LP | 7.43M | 5.92% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.58M | 3.65% | +140.8K | Aug 13, 2026 |
| Federated Hermes, Inc. | 3.11M | 2.48% | +172.2K | Aug 12, 2026 |
| State Street Corp | 2.93M | 2.33% | +381.8K | Aug 7, 2026 |
| Geode Capital Management, LLC | 2.62M | 2.09% | +214.7K | Aug 12, 2026 |
| Samsara Biocapital, LLC | 2.50M | 1.99% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Bratton Douglas K | 11.10% | 10.08M | 13G | Feb 13, 2025 |
| BlackRock, Inc. | 5.30% | 6.43M | 13G | Oct 17, 2025 |
| RTW Investments, LP | 5.20% | 6.25M | 13G | Nov 14, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 15, 2026 | Daniel Barberdirector, officer: President and CEO | Sale | 25,000 | $4.82 | 652,317 |
| Sep 9, 2026 | Sherry Korczynskiofficer: Chief Commercial Officer | Sale | 8,750 | $5.22 | 235,689 |
| Aug 17, 2026 | Daniel Barberdirector, officer: President and CEO | Sale | 25,000 | $4.29 | 585,574 |
| Jul 16, 2026 | Daniel Barberofficer: President and CEO | Sale | 20,369 | $4.00 | 610,574 |
| Jul 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 4,631 | $4.03 | 630,943 |
| Jun 23, 2026 | Julie Kropdirector | Sale | 25,000 | $5.02 | 0 |
| Jun 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 25,000 | $4.16 | 635,574 |
| May 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 8,257 | $4.29 | 660,574 |
| Mar 10, 2026 | Cassie Jungofficer: Chief Operating Officer | Sale | 45,791 | $4.17 | 274,980 |
| Mar 10, 2026 | Sherry Korczynskiofficer: Chief Commercial Officer | Sale | 15,741 | $4.17 | 241,117 |
House and Senate disclosures
Not reported.